Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE: Another no news Monday!

RE: Another no news Monday!

posted on May 01, 2006 01:13PM
Wrench,

The fully diluted share count is closer to 420M not 303M or 361M. There were warrants tied to the convertible debentures that are still outstanding which the company has begun repurchasing. Only when S/L converted all their debentures into shares is when they were officially added into the float/OS. The longs all should be aware of this mess that was created a few years back which the company has begun cleaning up. I don`t know how committed they are in really cleaning it up but at least they have begun. It`s a daunting task that could have been taken care of with allot less money before the share price broke out. I remember Brian suggested we take out a loan knowing the licenses would come through to buy back some of the float but no one there was listening. Now the share price is $1 and it will take 10x the $$ to purchase 1/10 the shares. So to sum it up we know all the debentures have been converted and added into the float so there ahould be no more dilution from that angle, however, there are warrants still outstanding that are not presently counted in the float/OS and will not be until S/L convert the warrants into shares. Depending on how many warrants the company buys back we should be around 420M +/-. This is why I wish they would buy back all the warrants BEFORE they commence a share buy back.

Hope this helps.

Share
New Message
Please login to post a reply